HRC Ledger
Opportunity

Sepsis Research Blood Sample Collection Services

Response due

October 15, 2026

Agency
Defense Health Agency
Estimated value
Not stated
Notice of Intent (NOI) to Sole Source Title: Sepsis Research Blood Sample Collection Services Requiring Activity: Walter Reed Army Institute of Research (WRAIR), Integrative Systems Biology (ISB) Branch Related Notice: HT942523P0084 Product Service Code (PSC): AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH North American Industry Classification System (NAICS) Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology) Small Business Size Standard: 1000 employees The Defense Health Agency Contracting Activity (DHACA) on behalf of the Integrative Systems Biology (ISB) Branch at the Walter Reed Army Institute of Research (WRAIR) intends to extend current contract services as a cost R&D contract on a sole source basis to Medstar Health Research Institute, Inc. (MHRI), 10980 Grantchester Way 7th Fl, Columbia, MD 21044-6097 USA; Cage Code 3J1M2 under the RFO FAR 6.103-1 – Only one responsible source can supply the required products due to the non-commercially available sources of the blood samples the Government is requesting. Description of Requirement: This is a requirement to extend and re-structure a Firm-Fixed Price contract into a Research and Development (R&D) cost type contract vehicle that will allow the Integrative Systems Biology (ISB) Branch to procure samples from septic and non-septic burn patients along with longitudinal clinical data for the assessment of biomarkers of sepsis for refinement and validation of SeptiBurnAlert program. These blood samples; to include longitudinal clinical data, are currently being collected by MHRI in accordance with an approved Institutional Review Board (IRB) protocol and are actively recruiting subjects for patient samples that meet the specific thermally injured criteria. The Government will convert the current contract from a firm fixed price award to a cost type, RFO part 35 R&D contract to better align the requirement with the Government’s needs. This special notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Meaningful submissions received in response to this notice will be considered solely for the purpose of determining whether competitive procurement is in the best interest of the Government. If no meaningful, written submissions are received by the date listed below, after the publication of this notice, the solicitation will be issued as a sole source requirement to Medstar Health Research Institute, Inc. Based on the above information, the only technically acceptable vendor to fulfill this requirement is MHRI. Submit capability statements (using PDF, MS Word, or Excel attachments) to Ms. Nicole Applegate at e-mail: nicole.v.applegate.civ@health.mil Capability statements are due no later than 10:00am Eastern Time on October 15, 2026.

Key dates

Posted
September 1, 2026
Response due
October 15, 2026

Who is this buyer

Department of Defense

Organization

Defense Health Agency

Buying history

  • Records738 total
  • Opportunities / awards15 / 562
  • Value range$0 – $300,000,000
  • ActiveApril 13, 2026 – October 27, 2026

What they buy

  • Clinical (687)
  • Administrative (46)
  • Insurance (5)

Set-asides used

  • No Set aside used (114)
  • Small Business Set Aside - Total (26)
  • 8(a) Set-Aside (FAR 19.8) (3)
  • WOSB Program Set-Aside (FAR 19.15) (2)

Who holds their work today

  1. DELOITTE CONSULTING LLP1 win · $300,000,000 · last August 6, 2026
  2. A SQUARE GROUP LLC1 win · $300,000,000 · last August 6, 2026
  3. GREAT HILL SOLUTIONS, LLC1 win · $300,000,000 · last August 6, 2026
  4. VISTA GLOBAL SOLUTIONS, LLC1 win · $300,000,000 · last August 6, 2026
  5. GENERAL DYNAMICS INFORMATION TECHNOLOGY, INC.1 win · $300,000,000 · last August 6, 2026

Also open from this buyer

View source document →

Source link on sam.gov.

Source record

Buyer type
Federal
Jurisdiction
Federal (US)
Category
Clinical
Set-aside
No Set aside used
NAICS
541714
PSC
AN11